One-Day brain zaps: a new hope for stubborn depression?

NCT ID NCT07758010

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether a single day of accelerated transcranial magnetic stimulation (TMS) can reduce depressive symptoms in adults with treatment-resistant depression. Participants are randomly assigned to receive one of two active TMS protocols—targeting the precuneus or the left dorsolateral prefrontal cortex—or a sham (inactive) treatment. The study compares changes in depression scores over four weeks to see if either active approach outperforms the placebo-like sham.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Transcranial magnetic stimulation (TMS) targeting the precuneus or the left dorsolateral prefrontal cortex
What this could lead to
If it works, this could offer a fast, non-invasive option for people with treatment-resistant depression, potentially easing symptoms within weeks.
What could go wrong
This is an early-stage trial, and the effects may be modest or not last. TMS can cause scalp discomfort or headache, and not everyone responds.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, TREATMENT-RESISTANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

depressive disorder Depressive Disorder, Treatment-Resistant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • McLean Hospital

    Belmont, Massachusetts, 02478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.